AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Intensive blood pressure control in patients with type 2 diabetes significantly reduces major adverse cardiovascular events (MACE). A recent trial demonstrated that lowering systolic blood pressure to less than 120 mmHg resulted in a 21% lower relative risk of MACE compared to a standard target of 140 mmHg. This reduction was primarily attributed to a decrease in stroke incidents, highlighting the importance of aggressive hypertension management in high-risk populations. The trial underscored previous guidelines suggesting that achieving a blood pressure below 130 could confer similar benefits, thus reinforcing the need for clinicians to aim for lower targets in line with emerging evidence.